2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T5202,

Summary Table

Feature	Detail
Risk Factors	Personal or family history of atopy (asthma, eczema, allergic rhinitis); environmental allergen exposure (pollen, dust mites, pet dander, mold)
Etiology	Type I (IgE-mediated) hypersensitivity reaction of the conjunctiva to airborne or contact allergens
Patient Presentation	Bilateral eye itching (pruritus is the hallmark), tearing, redness, and a stringy or watery discharge
Classic Physical Exam	Conjunctival injection with chemosis (edema of the conjunctiva), papillae on the tarsal conjunctiva, boggy and edematous eyelids; often coexists with rhinitis (allergic shiners, nasal crease)
Key Diagnostic Results	Clinical diagnosis; if tested, conjunctival scrapings show eosinophils; elevated serum IgE and positive skin prick tests support atopic background
Management	Allergen avoidance + cold compresses; topical antihistamine/mast cell stabilizer (olopatadine) as first-line pharmacotherapy; topical NSAIDs or short-course low-potency topical corticosteroids for refractory cases
Keywords	"Bilateral itchy eyes," "stringy/mucoid discharge," "seasonal worsening," "history of atopy," "cobblestone papillae," "chemosis"

1. Pathophysiology

Allergic conjunctivitis is driven by a Type I hypersensitivity reaction. Upon initial exposure to an allergen (pollen, dust mite proteins, animal dander), antigen-presenting cells in the conjunctival mucosa process the allergen and stimulate B cells to produce allergen-directed IgE antibodies. These IgE molecules bind to high-affinity FcεRI receptors on mast cells residing in the conjunctival substantia propria, completing the sensitization phase.

On re-exposure, the allergen cross-links adjacent surface-bound IgE molecules on mast cells, triggering degranulation. This releases preformed mediators, most importantly histamine, along with tryptase, prostaglandins, and leukotrienes. Histamine acts on H1 receptors on sensory nerve endings (producing the intense pruritus that defines this condition), on conjunctival blood vessels (producing vasodilation and the characteristic injection and chemosis), and on goblet cells (stimulating the watery-to-mucoid discharge).

The early phase reaction occurs within minutes and is predominantly histamine-driven. A late phase reaction follows 4 to 24 hours later, mediated by recruited eosinophils, basophils, and T-helper type 2 (Th2) lymphocytes releasing cytokines such as IL-4, IL-5, and IL-13. This late phase is responsible for prolonged inflammation and, in chronic forms, structural remodeling of the conjunctiva (giant papillae formation). The reason these patients almost always have bilateral involvement is that airborne allergens contact both eyes simultaneously, unlike infectious causes which often begin unilaterally.

2. Classification and Clinical Manifestation

Type	Timing	Key Features	Associations
Seasonal Allergic Conjunctivitis (SAC)	Recurs during specific pollen seasons (spring, fall)	Bilateral itching, tearing, conjunctival injection, mild papillae; symptoms wax and wane with pollen counts	Allergic rhinitis ("hay fever"); most common form overall
Perennial Allergic Conjunctivitis (PAC)	Year-round, with possible seasonal flares	Similar to SAC but milder and more persistent; triggered by indoor allergens (dust mites, mold, pet dander)	Perennial rhinitis, atopic dermatitis
Vernal Keratoconjunctivitis (VKC)	Chronic, seasonal exacerbations (warm climates, spring/summer)	Giant "cobblestone" papillae on upper tarsal conjunctiva, thick ropy/mucoid discharge, Horner-Trantas dots (limbal collections of eosinophils), shield ulcers on cornea	Young males (prepubertal), warm dry climates; risk of corneal scarring and vision loss
Atopic Keratoconjunctivitis (AKC)	Chronic, year-round	Bilateral lid eczema with thickened/fissured skin, papillae on lower tarsal conjunctiva, cicatrizing (scarring) conjunctivitis, corneal neovascularization	Adult males with longstanding atopic dermatitis; most sight-threatening form; associated with keratoconus and anterior subcapsular cataracts
Giant Papillary Conjunctivitis (GPC)	Related to mechanical irritation	Giant papillae on upper tarsal conjunctiva, mucoid discharge, lens intolerance	Contact lens wear, ocular prostheses, exposed sutures; not purely IgE-mediated

The distinction between the simple forms (SAC/PAC) and the severe forms (VKC/AKC) is high-yield. SAC and PAC are self-limited nuisances, while VKC and AKC carry the risk of corneal complications and permanent vision loss, changing the management approach entirely.

3. Diagnostic Workup

Test	Role	Expected Finding
Clinical history and exam	Best initial "test"	Bilateral pruritus + injection + watery/stringy discharge + atopic history; papillary reaction on lid eversion
Conjunctival scrapings	Supports diagnosis when uncertain	Eosinophils on cytology (distinguishes from infectious conjunctivitis, which shows neutrophils)
Serum total IgE	Confirms atopic background	Elevated
Skin prick testing / Specific IgE (RAST)	Identifies the causative allergen	Positive wheal-and-flare to relevant allergen
Slit-lamp examination	Evaluates severity, especially in VKC/AKC	Papillae grading, Horner-Trantas dots, shield ulcers, corneal pannus, conjunctival scarring
Fluorescein staining	Assesses corneal involvement	Punctate epithelial erosions or shield ulcers (VKC)

Allergic conjunctivitis is overwhelmingly a clinical diagnosis. The combination of bilateral pruritus, watery or stringy discharge, and a personal or family history of atopy is usually sufficient. Vignettes will often embed seasonal variation or known triggers to reinforce this.

When the presentation is ambiguous or severe, conjunctival scraping is the next step. Finding eosinophils confirms an allergic etiology and effectively excludes bacterial (neutrophil-predominant) and viral (lymphocyte-predominant) conjunctivitis. This is a commonly tested discriminator.

Skin prick testing or serum-based allergen panels are not used to diagnose conjunctivitis itself but rather to identify the offending allergen for avoidance counseling or immunotherapy planning. In the context of VKC or AKC, a slit-lamp exam with fluorescein staining becomes mandatory to detect corneal complications such as shield ulcers or neovascularization, which alter management urgency.

4. Management and Treatment

Severity / Type	Treatment	Details
All forms (baseline)	Allergen avoidance + cold compresses + artificial tears	Remove contact lenses if applicable; wash hands/face after exposure; cold compresses reduce chemosis and itch
Mild SAC/PAC (first-line)	Topical dual-action agent (antihistamine + mast cell stabilizer)	Olopatadine 0.1% one drop twice daily, or ketotifen 0.025% one drop twice daily; can also use olopatadine 0.2% once daily
Moderate SAC/PAC	Topical antihistamine/mast cell stabilizer + oral antihistamine	Add cetirizine 10 mg or loratadine 10 mg once daily if ocular symptoms accompany rhinitis
Refractory or moderate-severe	Short-course topical corticosteroid	Loteprednol 0.2% one drop four times daily for 1 to 2 weeks; must be time-limited due to risk of glaucoma, cataracts, and superinfection
VKC with shield ulcer	Topical corticosteroid (higher potency) + topical cyclosporine	Prednisolone acetate 1% every 2 hours initially, taper over weeks; topical cyclosporine 0.05 to 2% as steroid-sparing maintenance
AKC (chronic)	Topical cyclosporine or tacrolimus as maintenance	Cyclosporine 0.05% (Restasis) twice daily long-term; lid eczema treated with tacrolimus 0.03% ointment (avoid topical steroids on eyelid skin)
Severe/refractory VKC or AKC	Systemic immunotherapy or referral	Subcutaneous allergen immunotherapy for identified triggers; ophthalmology referral for corneal complications

Acute stabilization centers on removing the allergen and providing symptomatic relief. Cold compresses and artificial tears provide immediate comfort by diluting allergens in the tear film and physically reducing edema. Pharmacologically, the dual-action topical agents (olopatadine, ketotifen) are first-line because they simultaneously block H1 receptors (immediate relief) and stabilize mast cells (prevent further degranulation). Pure mast cell stabilizers like cromolyn sodium take 1 to 2 weeks to reach full efficacy, making them better suited for prophylactic use before allergy season rather than acute symptom control.

Topical corticosteroids should be reserved for moderate-to-severe flares unresponsive to first-line therapy and must always be prescribed in short, tapering courses under ophthalmologic supervision. The key contraindication to remember is that prolonged topical steroid use causes steroid-induced glaucoma (open-angle, from increased aqueous outflow resistance in the trabecular meshwork) and posterior subcapsular cataracts. This is a frequent test point.

For chronic severe disease (VKC, AKC), topical calcineurin inhibitors (cyclosporine, tacrolimus) serve as steroid-sparing agents. They suppress Th2 lymphocyte activation and reduce eosinophilic infiltration without the intraocular pressure and cataract risks of corticosteroids. An important clinical pearl: topical steroids should never be applied to eyelid skin in AKC because periocular skin is extremely thin and susceptible to atrophy and glaucoma from dermal absorption. Instead, tacrolimus ointment is used for lid eczema.

5. Differential Diagnosis and Distractors

Differential	Why It Looks Similar	Key Discriminator
Viral conjunctivitis (adenoviral)	Red eye, watery discharge, may be bilateral	Unilateral onset spreading to the other eye days later; preauricular lymphadenopathy; follicles (not papillae) on tarsal conjunctiva; recent URI or sick contact; no itching or only mild irritation rather than pruritus
Bacterial conjunctivitis	Red eye, discharge, bilateral possible	Purulent (thick yellow-green) discharge with morning crusting; neutrophils on scraping (not eosinophils); no atopic history; no itching as chief complaint
Dry eye syndrome	Chronic bilateral irritation, tearing, redness	Burning and foreign body sensation rather than itching; worse with prolonged screen use or low humidity; reduced tear breakup time; Schirmer test shows decreased tear production
Contact lens-related keratitis	Red eye in a contact lens wearer, discharge	Pain, photophobia, and ciliary flush (perilimbal injection); corneal infiltrate or ulcer on slit lamp; suggests infectious etiology rather than allergic
Anterior uveitis (iritis)	Red eye, photophobia, tearing	Unilateral deep aching pain; ciliary flush (circumcorneal injection, not diffuse); cells and flare in anterior chamber on slit lamp; constricted pupil; no discharge
Angle-closure glaucoma	Acute red eye, tearing	Unilateral; severe headache and nausea; fixed mid-dilated pupil; markedly elevated IOP; steamy cornea; this is an emergency, not an allergic process
Chlamydial conjunctivitis (inclusion)	Chronic bilateral conjunctivitis in young adults	Follicular (not papillary) reaction; mucopurulent discharge; concurrent urogenital symptoms; positive chlamydial NAAT

The single most reliable discriminator in any conjunctivitis vignette is the quality of the primary symptom. Allergic conjunctivitis presents with itching as the dominant complaint. Bacterial conjunctivitis leads with purulent discharge. Viral conjunctivitis presents with watery discharge and irritation but not true pruritus. Anterior uveitis and angle-closure glaucoma present with pain and photophobia, not itching. If the stem says "itchy eyes," think allergic until proven otherwise.

6. Traps and High-Yield Pearls

The most common way students miss questions on allergic conjunctivitis is by confusing discharge types and failing to anchor on the chief complaint. The vignette will describe a patient with bilateral red eyes, and the student must immediately classify the discharge (watery/stringy versus purulent) and the primary symptom (itching versus burning versus pain). Picking bacterial conjunctivitis for a patient whose chief complaint is itching with watery discharge and a history of seasonal allergies is a classic error.

A second trap involves VKC and AKC being mistaken for simple SAC. If the vignette describes a young boy in a warm climate with giant cobblestone papillae, ropy discharge, and corneal findings, this is VKC, not seasonal allergies. The management escalates to topical steroids and calcineurin inhibitors, and the question may test whether you recognize the risk of corneal scarring.

Third, students sometimes choose topical corticosteroids as first-line therapy. Topical steroids are never first-line for routine allergic conjunctivitis. The correct first-line answer is a dual-action topical antihistamine/mast cell stabilizer. The question may then test knowledge of steroid complications (glaucoma, cataracts, superinfection) as reasons for this sequencing.

Finally, remember the cytology pearl: eosinophils on conjunctival scraping confirm allergic etiology. Neutrophils point to bacterial, lymphocytes to viral, and basophils with granular debris to atopic or vernal keratoconjunctivitis. This cell-type correlation is a reliable way the exam tests whether you understand the underlying immunology.

The core competency being assessed is pattern recognition of allergic eye disease within the broader "red eye" differential, correct sequencing of therapy (avoidance and topical antihistamine/mast cell stabilizer before steroids), and recognition of sight-threatening complications in the chronic severe subtypes.

1e:["$","$L2d",null,{"article":{"id":"8fb2df99-bf9d-48d9-99f4-c52cbf29d472","title":"Konjungtivitis Alergi","content":"$2e","category":"Oftalmologi","created_at":"2026-05-13T06:52:13.056085+00:00","status":"published","subcategory":null},"questionCount":4,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]